# MASSACHUSETTS GENERAL HOSPITAL: Phase 2 Study of EPN-701 for Treatment of Calciphylaxis (IND: 129344; September 14, 2022)

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | MASSACHUSETTS GENERAL HOSPITAL |
| Location | BOSTON, MA |
| Project | Phase 2 Study of EPN-701 for Treatment of Calciphylaxis (IND: 129344; September 14, 2022) |
| Project number | 1R01FD008525-01A1 |
| Mechanism | R01 |
| Institute | Food and Drug Administration |
| Award | $2,462,415 |
| Awarded | 2026-09-29 |
| Project period | 2026-09-01 to 2030-08-31 |
| UEI | FLJ7DQKLL226 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11443555). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.